Abstract
The aim of this study was to investigate the metabolic trajectory of liver aging, the effect of FTZ against liver aging in aging mice, and its mechanism using ultraperformance liquid chromatography/quadrupole-time-of-flight mass spectrometry (UPLC-Q-TOF/MS). Methods: A total of 80 C57BL/6J Narl mice were randomly divided into five groups: 3-month-old group, 9-month-old group, 14-month-old group, 20-month-old group, and FTZ treatment group (20 months old). The mice in the treatment group received a therapeutic dose of oral FTZ extract (1.0 g/kg, on raw material weight basis) once daily during the experiment. The other groups received the corresponding volume of oral normal saline solution. Liver samples of all five groups were collected after 12 weeks, and UPLC-Q-TOF/MS was used to analyze metabolic changes. Orthogonal partial least squares–discriminant analysis (OPLS-DA) was used to analyze the resulting data. Additionally, cholesterol (TC), triglyceride (TG), aspartate aminotransferase (AST), alanine aminotransferase (ALT), secretion levels of TNF-α, IL-6, 5-LOX, and COX-2, as well as their relative mRNA expression in the liver were determined. Results: The levels of TC, TG, AST, and ALT were increased, and liver tissue structure was damaged. The secretion levels of TNF-α, IL-6, 5-LOX, and COX-2, as well as their relative mRNA expression in the liver also increased with aging. FTZ administration reduced the symptoms of liver aging. The OPLS-DA score plot illustrated the effect of FTZ against liver aging, with N-acetyl-leukotriene E4, 20-hydroxy-leukotriene E4, leukotriene E4, and arachidonic acid among the key biomarkers. The pivotal pathways revealed by pathway analysis included arachidonic acid metabolism and biosynthesis of unsaturated fatty acids. The mechanism by which FTZ reduces the symptoms of liver aging in mice might be related to disorders of the abovementioned pathways. Conclusion: A metabolomic approach based on UPLC-Q-TOF/MS and multivariate statistical analysis was successfully applied to investigate the metabolic trajectory of liver aging. FTZ has a protective effect against liver aging, which may be mediated via interference with the metabolism of arachidonic acid, biosynthesis of unsaturated fatty acids, and downregulation of pro-inflammatory factors in the liver in mice in vivo.
Highlights
As the global population continues to age, the health status of middle-aged and elderly people continues to decline, which is likely to increase age-related health burdens such as hypertension, diabetes, and cardiovascular and other chronic diseases (De Luca d’Alessandro et al, 2011)
The liver plays a central role in metabolism, and studies have shown that insulin resistance associated with dysregulation of lipid metabolism in the elderly can lead to an increased stress response which significantly decreases this organ’s various functions, causing a variety of liver diseases
The level of cholesterol increased with age, and bile acids are the end-product of cholesterol catabolism (Staley et al, 2016), indicating that bile acid metabolism and cholesterol metabolism disorders occurred with increasing age, and FuFang Zhenzhu TiaoZhi (FTZ) treatment partially reversed these bile acid abnormalities
Summary
As the global population continues to age, the health status of middle-aged and elderly people continues to decline, which is likely to increase age-related health burdens such as hypertension, diabetes, and cardiovascular and other chronic diseases (De Luca d’Alessandro et al, 2011). According to a recent study of the glucose metabolism status in middle-aged and elderly people, the pre-diabetes and diabetes prevalence rates were increasing with age (Song, 2017). Studies have shown that liver aging is associated with liver regeneration, stress response, and inflammatory response (Gan et al, 2011). Liver aging is closely related to the severity and progression of nonalcoholic fatty liver disease, nonalcoholic steatohepatitis, and metabolic syndrome (especially diabetes and obesity) (Frith et al, 2008; Honma et al, 2011; Tomás-Loba et al, 2012; Wuttke et al, 2012)
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.